EMPHASYS Acetabular System
by DePuy Ireland UC 2 variants
510(k) K243977
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK243977 | Date22 Jan 2025 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- LPH
- Device class
- Class II
- Regulation
- 21 CFR Part 888.3358
- Advisory committee
- Orthopedic
- FDA decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 26 Sep 2026
The Emphasys Acetabular System is a semi-constrained hip prosthesis designed for use in orthopedic surgical procedures. It functions as an acetabular component to support hip joint reconstruction.
This device is identified by FDA 510(k) number K243977 and is classified under product code LPH. It has received FDA 510(k) clearance through the Special 510(k) pathway.
Other devices from DePuy Ireland UC
Questions
AI-generated answers, 26 Sep 2026
What is the primary function of the EMPHASYS Acetabular System?
The EMPHASYS Acetabular System is a semi-constrained hip prosthesis intended for use in orthopedic surgical procedures. It serves as an acetabular component to provide structural support during hip joint reconstruction.
What is the regulatory status of this device?
The EMPHASYS Acetabular System has received FDA 510(k) clearance, identified by submission number K243977. It was cleared through the Special 510(k) pathway and is classified under product code LPH.
Who is the manufacturer of the EMPHASYS Acetabular System?
This device is manufactured by DePuy Ireland UC, located in Loughbeg, Ringaskiddy, Cork, Ireland.